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NetDiff – Bayesian model selection 
for differential gene regulatory 
network inference
Thomas Thorne
Differential networks allow us to better understand the changes in cellular processes that are exhibited 
in conditions of interest, identifying variations in gene regulation or protein interaction between, for 
example, cases and controls, or in response to external stimuli. Here we present a novel methodology 
for the inference of differential gene regulatory networks from gene expression microarray data. 
Specifically we apply a Bayesian model selection approach to compare models of conserved and 
varying network structure, and use Gaussian graphical models to represent the network structures. 
We apply a variational inference approach to the learning of Gaussian graphical models of gene 
regulatory networks, that enables us to perform Bayesian model selection that is significantly more 
computationally efficient than Markov Chain Monte Carlo approaches. Our method is demonstrated to 
be more robust than independent analysis of data from multiple conditions when applied to synthetic 
network data, generating fewer false positive predictions of differential edges. We demonstrate the 
utility of our approach on real world gene expression microarray data by applying it to existing data 
from amyotrophic lateral sclerosis cases with and without mutations in C9orf72, and controls, where we 
are able to identify differential network interactions for further investigation.
There has been much work in the literature on the inference of networks from gene expression data, utilising 
a variety of approaches including tests for correlation1, graphical models2,3, and mutual information based 
approaches4. Graphical modelling approaches have the advantage that they consider conditional independence, 
so that regulatory network interactions are only predicted where the other explanatory variables are unable to 
account for all of the variation observed.
A task that has received less attention, but would allow for greater exploitation of the experimental data that is 
often generated, is the inference of differential networks5–9. The aim of differential network inference approaches 
is similar to that of tests for differential expression, but rather than detecting changes in the expression of a 
single gene, the aim is to infer changes in the regulatory network structure itself between multiple conditions. 
This allows for more specific mechanistic insights into the molecular processes underlying changes between, for 
example, cases and controls in a disease study6,8.
In previous work we have explored the application of flexible non-parametric models of regulatory networks 
that allow for changes in network structure with an arbitrary number of networks8. However this flexibility adds 
complexity to the model that does not necessarily deliver greater insights, at the expense of a complex and com-
putationally demanding implementation. In a Bayesian framework, a parsimonious approach would seem to be 
applying Bayesian model selection to compare a model allowing for a change in the network structure between 
conditions against a model of a static network. Bayesian model selection approaches automatically compensate 
for changes in the number of parameters between models, so that a more complex model will not always improve 
on a simpler nested model by overfitting the data.
Although differential networks can be learnt through the independent analysis of samples of gene expression 
data from multiple conditions, as the process suffers from the “large p small n” problem, it would be expected that 
a substantial proportion of the differential edges observed would be a side-effect of false positive or false negative 
predictions. Instead we propose to compare a model of no change between conditions, against a model where 
edges are allowed to vary, for each gene independently. This allows the network edges of genes whose interactions 
do not vary to be learnt more robustly by utilising the data from both conditions, whilst where there is evidence 
of a change in the network, differential edges are identified.
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Here we propose a fast and easily applicable method to perform Bayesian model selection on gene expression 
microarray data collected between multiple conditions, and demonstrate an application of this method to publicly 
available gene expression microarray data from Amyotrophic Lateral Sclerosis (ALS) cases and controls, investi-
gating the impact of C9orf72 GGGGCC repeat expansions in the underlying regulatory network by comparing 
patients with and without these mutations.
Methods
Gaussian graphical models. In a Gaussian Graphical Model (GGM) a set of random variables X1, … , Xp 
are assumed to take a multivariate normal distribution so that µ∼ ΣX ( , ) . Then in a graphical representation 
of such a model, pairs of nodes i and j have no edge between them if and only if the two corresponding random 
variables are conditionally independent, or equivalently Σ =− 0ij
1 . Identifying such relationships is possible using 
the partial correlation between pairs of random variables Xi and Xj with respect to the remaining variables Z−i,j, 
defined as
ρ =
−Σ
Σ Σ
⋅
−
− −
− ,
(1)
X X Z
i j
i i j j
,
1
,
1
,
1
i j i j,
so that an edge from variable i to j exists in the graphical model iff ρ ≠⋅ − 0X X Zi j i j, . Unfortunately in many cases of 
interest, such as the analysis of gene expression microarray data, we are faced with the so called “large p small n” 
problem, characterised by a large number of variables p and a comparatively small number of observations n. In 
such cases it is not possible to directly calculate the partial correlations between the variables as the empirical 
covariance matrix will be singular. Fortunately however there are a number of ways that we can determine the 
partial correlations in such cases10.
One such method to infer the structure of a GGM when we are faced with more variables than observations is to 
use regularised regression methods to infer the partial correlations between the nodes. If the vector of n observations 
of variable i is denoted Y = Xi and the remaining variables as X−i = Xj≠i, then we seek to infer the posterior of βi with
β ε= +−Y X , (2)i i
where ε σ∼ (0, )2 . Then given βi for each variable i, we can estimate the partial correlations between variables 
i and j as ref. 10
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Here we apply the regularised regression method introduced in Caron et al.11, which has been demonstrated to 
outperform the lasso and other regularised regression methods. Sparsity is enforced by introducing a scale mix-
ture of Gaussian distributions as the prior on the regression coefficients βw11 (omitting indices of β, ζ2 and σ2 over 
the m variables for clarity),
∫β β ζ ζ ζ=p p d( ) ( ; 0, ) ( ) , (4)w w w w w2 2 2
with each ζw
2 in turn distributed as an inverse Gaussian,
ζ α γ∼ ( , ), (5)w
2 IG
where the parameters α and γ control the penalty placed on the βw, here set to 0.1 and 1 respectively. We place a 
vague gamma prior on σ2. To evaluate equation 3 we take the maximum a posteriori (MAP) estimates of βj
i to derive 
partial correlations ρ. Significant partial correlations are identified using the fdrtool R package12 to estimate 
the local false discovery rate, with a cutoff of 0.025.
Differential networks. To test for variation in the network structure between conditions, we allow the n 
observations to be partitioned into K sets, X1, … , XK. Here we focus on the case where K = 1 or K = 2, being 
models of a single network for all observations, and a network varying between two conditions, respectively. 
Considering the regression approach described in the previous section it is straightforward to allow for independ-
ent network structures between the K sets of observations,
∏ ∏β ζ σ β σ β ζ ζ σ∝







p Y X p Y X p p p( , , , ) ( , , ) ( ( ) ( )) ( ), (6)
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and for a given model M we can then consider the model evidence,
∫= Θ Θ ΘΘp X M p X M p M d( ) ( , ) ( ) , (7)
where the model parameters are subsumed into Θ . Comparing the two competing models K = 1 and K = 2, we 
can calculate a Bayes factor =
=
p X M
p X M
( )
( )
K
K
2
1
 to assess if there is significant evidence for preferring one model over the 
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other, and in our method we take a Bayes factor larger than 2 as support for model MK=2. Having calculated Bayes 
factors for each variable X1, … , Xp we can derive partial correlations for the two conditions k = 1 and k = 2 from 
the appropriate βkw.
Data: Gene expression microarray data X for M genes, a partition of X into two subsets, number of iterations to run variational inference S.
for i ∈ 1 … M do
  Partition observations Y = Xi and X−i into Y1, −X i1  and Y2, 
−X i2 ;
  Initialise variational parameters for the two partitions, β1, ζ1
2, β2, ζ2
2 and σ2;
  for s ∈ 1 … S do
     Update variational parameters for β1 based on ζ1
2, σ2, Y1, −X i1 ;
     Update variational parameters for ζ1
2 based on β1, σ2, Y1, −X i1 ;
     Update variational parameters for β2 based on ζ2
2, σ2, Y2, −X i2 ;
     Update variational parameters for ζ2
2 based on β2, σ2, Y2, −X i2 ;
     Update variational parameters for σ2 based on β, ζ2, Y, X;
  end
  Set A1 ← MAP(β1);
  Set A2 ← MAP(β2);
  Calculate model evidence p(X|MK=2);
  Initialise variational parameters for β, ζ2 and σ2;
  for s ∈ 1 … S do
     Update variational parameters for β based on ζ2, σ2, Y, X−i;
     Update variational parameters for ζ2 based on β, σ2, Y, X−i;
     Update variational parameters for σ2 based on β, ζ2, Y, X−i;
  end
  Set B ← MAP(β);
  Calculate model evidence p(X|MK=1);
  if  >
=
=
2p X M Kp X M K
( 2)
( 1)  then
     Set ←C Ai
1 1;
     Set ←C Ai
2 2;
  else
     Set ←C Bi
1 ;
     Set ←C Bi
2 ;
  end
end
for i ∈ 1 … M do
  for j ∈ 1 … M do
     Calculate ρ ⋅ −ij Z ij
1  from C1;
     Calculate ρ ⋅ −ij Z ij
2  from C2;
  end
end
Apply fdrtool to estimate local FDR of all ρ ⋅ −ij Z ij;
Generate network for condition 1 with M nodes, and edges (i, j) where local FDR of ρ < .⋅ − 0 025ij Z ij
1 ;
Generate network for condition 2 with M nodes, and edges (i, j) where local FDR of ρ < .⋅ − 0 025ij Z ij
2 ;
Algorithm 1: Outline of the inference procedure. Variational parameter updates and model evidence are 
given in the Supplementary methods. MAP refers to the Maximum A Posteriori value.
Implementation. To allow us to derive approximate posterior distributions of the model parameters, and 
perform model selection by estimating the model evidence, we apply a variational Bayes13–17 inference scheme 
to our model. An outline of the methodology is given in Algorithm 1, and derivations of the variational updates 
given in the Supplementary methods.
A benefit of the variational inference approach is that as well as providing a fast approximation of the posterior 
distribution, it allows for the evaluation of a lower bound on the log evidence p(x|M) for a model M, used as an 
approximation to p(x|M) in calculating the Bayes factor. The model evidence p(x|M) is not typically available 
when utilising Markov Chain Monte Carlo (MCMC) methods, and so model selection using MCMC methods 
typically requires more complex approaches such as Reversible Jump MCMC18.
www.nature.com/scientificreports/
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The method described was implemented as a package for the R Statistical Computing Environment19 and is 
available from https://gitlab.com/tt104/NetDiff. In benchmarking the method we also apply the GeneNet2 and 
FastGGM3 R packages.
Synthetic network benchmarking. The GeneNet2 R package was used to simulate partial correlations 
between sets of variables of varying sizes, and to generate observations of the variables under these network 
structures. To assess performance in network inference we calculate the area under the Receiver Operating 
Characteristic (ROC) curve using the PRROC R package20. This was repeated for multiple synthetic network 
structures to generate the distributions of metrics shown in the boxplots in Figs 1, 2 and 3.
Results
Synthetic data. We compare our approach to two existing methods from the literature to learn Gaussian 
graphical models from gene expression microarray data, GeneNet and FastGGM. The running time of our 
method, and of GeneNet and FastGGM was benchmarked on the synthetic data, see Supplementary Fig. 1. 
Although our method is slower, the running times for all methods are short, on the order of seconds, so that in 
practice this will be unlikely to have any real impact. The variational inference approach is considerably more 
computationally efficient when compared to MCMC approaches, for example in a previous method we developed 
applying a similar sparse regression method in a Gibbs sampling framework, inference took around 20 hours 
running in parallel on a 12 core CPU8.
Network inference. Applying our method to synthetic data with varying network sizes and numbers of obser-
vations, we see from the plots in Fig. 1 that our method performs well in terms of the area under the ROC curve, 
and is comparable to the other approaches that were benchmarked. Although the performance of our method 
does not exceed that of competing methods, by working in a Bayesian framework we are easily able to expand the 
approach to perform Bayesian model selection, as described in the following section. There are further benefits to 
the Bayesian approach, such as the straightforward inclusion of prior information. As expected, the performance 
of the various approaches decreases as the number of samples is reduced, and also falls as the size of the network 
grows for a given number of samples.
Differential networks. We test the main focus of our method, the learning of differential networks though 
Bayesian model selection, by generating synthetic data sets where the network structure is known to change for 
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Figure 1. Boxplots of Area Under Curve (AUC) of the receiver operating characteristic curve for each 
of the methods compared on random networks, with various numbers of network nodes and simulated 
sample data points from each network. 
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a subset of nodes between two sets of samples, in networks of 50 nodes. To benchmark our method we calculate 
the Matthews Correlation Coefficient (MCC), comparing the nodes with predicted changes to the known set of 
positives. Matthews correlation coefficient allows us to test the performance of our method at a specific cut-off, 
without concerns about effects of class imbalances. To test our hypothesis that a method performing integrated 
analysis between conditions and attempting to identify evidence for a change in network structure will perform 
better than independent analyses of each condition, we also compare the performance of GeneNet and FastGGM 
in identifying nodes whose network interaction partners change between conditions, taking significant edges 
as those with a local false discovery rate under 0.025 and testing for changes in the inferred networks between 
conditions.
From the results shown in Fig. 2, it is apparent that for 15 or more samples our approach outperforms the 
alternative methods, demonstrating higher Matthews correlation coefficient values than GeneNet, and to a lesser 
extent FastGGM. Our approach has less variance in performance than FastGGM, likely due to the greater suscep-
tibility to noise inherent in learning differential networks from independent analyses. However our method does 
require a relatively large number of samples per condition to effectively predict changes in the network structure, 
as can be seen in the case for 10 samples.
To further test the robustness of our approach, we also apply the method to synthetic data from two condi-
tions, where the network structure does not change between conditions, as shown in Fig. 3. As there are no true 
positive differential edges, we only measure the false positive rate, which for our method is significantly lower 
than applying GeneNet or FastGGM to each condition independently. This is to be expected, as our method 
is able to identify that there is no change in the network structure, and learn using data from both conditions 
combined, whilst the other approaches must learn networks independently from each condition, and differential 
edges may be erroneously identified simply due to noise in the output.
Dysregulation of gene expression in ALS patients with C9orf72 mutations. To test the appli-
cability of our approach to real world datasets we applied our method to the data of Cooper-Knock et al.21, 
Gene Omnibus accession GSE68607, consisting of gene expression microarray data collected from lymphoblas-
toid cell lines derived from 54 ALS patients and 15 controls. The ALS patients are further divided into 31 with 
C9orf72 mutations and 23 without. Hexanucleotide repeat expansions in C9orf72 have been shown to cause 
familial ALS22, but the exact mechanisms are not understood. To identify the causal mechanisms by which these 
expansions lead to ALS, we seek to investigate the differences in gene regulation between controls and ALS cases 
with and without expansions. We do so by comparing gene expression microarray data from each subclass of ALS 
patients to one another, and to controls, identifying differential network edges using our proposed method. To 
samples: 10 samples: 15 samples: 20 samples: 25 samples: 30
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Figure 2. Boxplots of Matthews Correlation Coefficient (MCC) for each of the methods applied to random 
networks with structures varying between conditions, with various different numbers of samples per 
condition. 
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render the analysis tractable we choose a subset of the genes in the dataset to focus on in our study, specifically 
those in the KEGG database23,24 ALS pathway, accession hsa05014, as well as C9orf72.
Firstly considering the differential networks inferred between cases without C9orf72 mutations and controls, 
as shown in Fig. 4, we see that whilst the majority of network edges are conserved, there appear to be a small 
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Figure 3. Boxplots of False Positive Rate (FPR) for each of the methods applied to random networks 
with structures remaining identical between conditions, with various different numbers of samples per 
condition. 
Figure 4. Differential network comparing ALS cases without C9orf72 mutations and controls. Conserved 
network edges are shown in grey, whilst edges only present in ALS cases are in red, and those only present in 
controls are in blue.
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number of genes whose interactions change considerably. Several regulatory interactions are gained by GPX1, to 
PPP3R1, CASP1, TNF, all promoters of apoptosis, and MAPK13 and MAPK14. The interaction between BID and 
GPX1 is only observed in controls. BCL2 loses interactions with SOD1, BCL2L1, TNF and MAPK11, whilst gain-
ing an interaction with RAC1. Interestingly, BCL2 is crucial in inhibiting apoptosis, and has been demonstrated 
to have reduced expression in ALS in mice25. RAC1, thought to be a key player in immune response in ALS26, also 
gains an interaction with MAP2K6.
Changes within the set of ALS patients, between those with and without mutations in C9orf72, are less pro-
nounced, as seen in Fig. 5. Interestingly cases with a C9orf72 mutation gain an interaction with MAPK14, whilst 
Figure 5. Differential network comparing ALS cases with and without C9orf72 mutations. Conserved 
network edges are shown in grey, whilst edges only present in ALS cases with C9orf72 mutations are in blue, and 
those only present in ALS cases without C9orf72 mutations are in red.
Figure 6. Differential network comparing ALS cases with C9orf72 mutations and controls. Conserved 
network edges are shown in grey, whilst edges only present in ALS cases with C9orf72 mutations are in red, and 
those only present in controls are in blue.
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MAPK14 and CASP9 do not interact in cases with a C9orf72 mutation. Furthermore CASP1 gains interactions 
with BAX, TNFRSF1B and GRIN2B, whilst losing interactions with BAD and BID. CASP1, BAD, BAX and BID 
all promote apoptosis, whilst TNFRSF1B inhibits apoptosis. GRIN2B encodes NR2B, which activates apoptosis 
when overexpressed27.
We also compare patients with mutations in C9orf72 with controls, again giving less pronounced results, 
shown in Fig. 6. In patients with C9orf72 mutations, BAD appears to lose an interaction with CAT, and gain one 
with TNF. As mentioned previously TNF is a promoter of apoptosis, again showing dysregulation of apoptosis as 
a potential mechanism of ALS28.
Genes having gene ontology annotations for positive regulation of apoptosis were found to be significantly 
differentially expressed in microarray data from lymphoblastoid cell lines derived from ALS cases with C9orf72 
mutations21, and our results suggest that there may be differences in regulation of apoptosis between ALS cases 
with and without C9orf72 mutations.
It should be highlighted that the network edges (interactions) in inferred graphical models from gene expres-
sion data do not necessarily correspond to direct regulatory interactions in the form of transcription factor bind-
ing, but may take the form of the indirect modulation of transcription through the action of intermediary steps 
that are not measured by transcriptomic studies.
Discussion
We demonstrate that our Bayesian model selection approach is able to identify changes in network structures 
between conditions. Whilst the performance of our approach in learning the network structure under a single 
condition does not improve on competing methods, the focus is in this work to allow for the inference of dif-
ferential networks to allow gene expression microarray data from case control studies to be fully exploited. The 
model selection approach we describe here is enabled by the variational inference scheme we employ that allows 
us to estimate the model evidence in a computationally efficient manner, and we show that it allows us to more 
robustly identify differential regulatory interactions between conditions. Due to the challenging nature of the 
task of learning a network from microarray data, likely introducing noise in the results, an integrated approach 
that can utilise all of the samples whilst testing for changes in the network structure is preferable to independent 
learning on cases and controls, as we demonstrate here.
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